Biocon informs about press release

04 Jun 2016 Evaluate

Biocon has informed about a Press Release dated June 03, 2016 titled ‘Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

378.30 9.20 (2.49%)
25-Mar-2026 15:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.00
Dr. Reddys Lab 1301.90
Cipla 1243.90
Zydus Lifesciences 903.60
Lupin 2347.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×